Literature DB >> 27015034

Two Subtypes of Atypical Leiomyoma: Clinical, Histologic, and Molecular Analysis.

Julianne M Ubago1, Qing Zhang, Julie J Kim, Beihua Kong, Jian-Jun Wei.   

Abstract

Atypical leiomyoma (ALM) is a rare variant of uterine smooth muscle tumors. Several recent studies have suggested that ALM has distinct, but also heterogenous, histologic and molecular features, yet little is known about the biology and histogenesis of ALM. Some have even postulated whether the atypical histologic features represent true atypia or simply degenerative changes. In this study, we analyzed the cytologic features of 60 ALM cases and found that ALM could be further divided into 2 subtypes, type I and type II, based primarily on nuclear features. Type I ALM showed round or oval nuclei, distinct and smooth nuclear membranes, prominent nucleoli with perinucleolar halos, and open coarse chromatin. Type II ALM showed elongated or spindled nuclei, irregular nuclear membranes, pinpoint or no nucleoli, and dark smudgy chromatin. There were also architectural differences between type I and type II ALM. Type I ALM often showed diffuse atypia within the tumor, whereas the atypia in type II ALM was patchy, surrounded by usual-type leiomyoma. The 2 subtypes also differed when we compared the immunohistochemical and molecular patterns. Type II tumors showed significantly higher rates of immunoreactivity for p16, p53, and HMGA2 and showed MED12 mutations more frequently than the type I counterparts. Our findings suggest that the type I and type II subtypes of ALM may arise from 2 different pathways. Type I tumors may be related to fumarate hydratase mutations, whereas type II ALM appear to arise in a existing usual-type leiomyomas.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27015034      PMCID: PMC5777155          DOI: 10.1097/PAS.0000000000000646

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

1.  Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma.

Authors:  Qing Zhang; Julianne Ubago; Li Li; Haiyang Guo; Yugang Liu; Wenan Qiang; J Julie Kim; Beihua Kong; Jian-Jun Wei
Journal:  Cancer       Date:  2014-07-01       Impact factor: 6.860

2.  Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up.

Authors:  K A Downes; W R Hart
Journal:  Am J Surg Pathol       Date:  1997-11       Impact factor: 6.394

3.  Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.

Authors:  S W Bell; R L Kempson; M R Hendrickson
Journal:  Am J Surg Pathol       Date:  1994-06       Impact factor: 6.394

4.  MED12 exon 2 mutations in histopathological uterine leiomyoma variants.

Authors:  Netta Mäkinen; Pia Vahteristo; Kati Kämpjärvi; Johanna Arola; Ralf Bützow; Lauri A Aaltonen
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

5.  Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas.

Authors:  Khush R Mittal; Fan Chen; Jian J Wei; Kiran Rijhvani; Rohini Kurvathi; Deanna Streck; James Dermody; Gokce A Toruner
Journal:  Mod Pathol       Date:  2009-07-24       Impact factor: 7.842

6.  Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up.

Authors:  Anne M Mills; Amy Ly; Bonnie L Balzer; Michael R Hendrickson; Richard L Kempson; Jesse K McKenney; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2013-05       Impact factor: 6.394

7.  Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients.

Authors:  Nancy M Joseph; David A Solomon; Norma Frizzell; Joseph T Rabban; Charles Zaloudek; Karuna Garg
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

8.  MED12 alterations in both human benign and malignant uterine soft tissue tumors.

Authors:  Gaëlle Pérot; Sabrina Croce; Agnès Ribeiro; Pauline Lagarde; Valérie Velasco; Agnès Neuville; Jean-Michel Coindre; Eberhard Stoeckle; Anne Floquet; Gaëtan MacGrogan; Frédéric Chibon
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

9.  MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.

Authors:  Elizabeth Bertsch; Wenan Qiang; Qing Zhang; Margarita Espona-Fiedler; Stacy Druschitz; Yu Liu; Khush Mittal; Beihua Kong; Takeshi Kurita; Jian-Jun Wei
Journal:  Mod Pathol       Date:  2014-01-03       Impact factor: 7.842

10.  Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry.

Authors:  Carolina Reyes; Yevgeniy Karamurzin; Norma Frizzell; Karuna Garg; Daisuke Nonaka; Ying-Bei Chen; Robert A Soslow
Journal:  Mod Pathol       Date:  2013-12-06       Impact factor: 7.842

View more
  7 in total

Review 1.  Leiomyoma with nuclear atypia: Rare diseases that present a common diagnostic problem.

Authors:  Jian-Jun Wei
Journal:  Semin Diagn Pathol       Date:  2022-02-02       Impact factor: 3.893

2.  Uterine Leiomyosarcoma Associated With Leiomyoma With Bizarre Nuclei: Histology and Genomic Analysis of 2 Cases.

Authors:  Jean V Fischer; Melissa Mejia-Bautista; Brian Vadasz; Ping Yin; Serdar Bulun; Edward J Tanner; Xinyan Lu; Jian-Jun Wei
Journal:  Int J Gynecol Pathol       Date:  2022-01-31       Impact factor: 3.326

3.  Fumarate Hydratase Mutations and Alterations in Leiomyoma With Bizarre Nuclei.

Authors:  Qing Zhang; Kate Poropatich; Julianne Ubago; Jia Xie; Xiuhua Xu; Norma Frizzell; Julie Kim; Beihua Kong; Jian-Jun Wei
Journal:  Int J Gynecol Pathol       Date:  2018-09       Impact factor: 2.762

4.  Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases.

Authors:  Markku Miettinen; Anna Felisiak-Golabek; Bartosz Wasag; Magdalena Chmara; Zengfeng Wang; Ralf Butzow; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

5.  Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.

Authors:  Netta Mäkinen; Kati Kämpjärvi; Norma Frizzell; Ralf Bützow; Pia Vahteristo
Journal:  Mol Cancer       Date:  2017-06-07       Impact factor: 27.401

6.  Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases.

Authors:  Jennifer A Bennett; Britta Weigelt; Sarah Chiang; Pier Selenica; Ying-Bei Chen; Ann Bialik; Rui Bi; Anne M Schultheis; Raymond S Lim; Charlotte K Y Ng; Vicente Morales-Oyarvide; Robert H Young; Victor E Reuter; Robert A Soslow; Esther Oliva
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

7.  Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia.

Authors:  Tingting Gao; Brian S Finkelman; Yanli Ban; Yinuo Li; Ping Yin; Serdar E Bulun; Xinyan Lu; Chunfang Ha; Jian-Jun Wei
Journal:  Cancer Sci       Date:  2021-03-22       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.